Global GLP-1 Drug Peptide API Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global GLP-1 Drug Peptide API market size was valued at US$ million in 2022. With growing demand in downstream market, the GLP-1 Drug Peptide API is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global GLP-1 Drug Peptide API market. GLP-1 Drug Peptide API are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of GLP-1 Drug Peptide API. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the GLP-1 Drug Peptide API market.
GLP-1 (Glucagon-Like Peptide-1) drugs are a class of drugs used to treat type 2 diabetes and obesity, usually prepared in the form of polypeptides. These drugs mimic the GLP-1 hormone in the body, causing the release of insulin and controlling blood sugar levels. Peptide APIs are the starting components of these drugs, typically synthesized or produced in laboratories and used in further formulation preparations.
Key Features:
The report on GLP-1 Drug Peptide API market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the GLP-1 Drug Peptide API market. It may include historical data, market segmentation by Type (e.g., Semaglutide, Liraglutide), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the GLP-1 Drug Peptide API market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the GLP-1 Drug Peptide API market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the GLP-1 Drug Peptide API industry. This include advancements in GLP-1 Drug Peptide API technology, GLP-1 Drug Peptide API new entrants, GLP-1 Drug Peptide API new investment, and other innovations that are shaping the future of GLP-1 Drug Peptide API.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the GLP-1 Drug Peptide API market. It includes factors influencing customer ' purchasing decisions, preferences for GLP-1 Drug Peptide API product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the GLP-1 Drug Peptide API market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting GLP-1 Drug Peptide API market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the GLP-1 Drug Peptide API market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the GLP-1 Drug Peptide API industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the GLP-1 Drug Peptide API market.
Market Segmentation:
GLP-1 Drug Peptide API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global GLP-1 Drug Peptide API market?
What factors are driving GLP-1 Drug Peptide API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do GLP-1 Drug Peptide API market opportunities vary by end market size?
How does GLP-1 Drug Peptide API break out type, application?
According to our LPI (LP Information) latest study, the global GLP-1 Drug Peptide API market size was valued at US$ million in 2022. With growing demand in downstream market, the GLP-1 Drug Peptide API is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global GLP-1 Drug Peptide API market. GLP-1 Drug Peptide API are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of GLP-1 Drug Peptide API. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the GLP-1 Drug Peptide API market.
GLP-1 (Glucagon-Like Peptide-1) drugs are a class of drugs used to treat type 2 diabetes and obesity, usually prepared in the form of polypeptides. These drugs mimic the GLP-1 hormone in the body, causing the release of insulin and controlling blood sugar levels. Peptide APIs are the starting components of these drugs, typically synthesized or produced in laboratories and used in further formulation preparations.
Key Features:
The report on GLP-1 Drug Peptide API market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the GLP-1 Drug Peptide API market. It may include historical data, market segmentation by Type (e.g., Semaglutide, Liraglutide), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the GLP-1 Drug Peptide API market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the GLP-1 Drug Peptide API market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the GLP-1 Drug Peptide API industry. This include advancements in GLP-1 Drug Peptide API technology, GLP-1 Drug Peptide API new entrants, GLP-1 Drug Peptide API new investment, and other innovations that are shaping the future of GLP-1 Drug Peptide API.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the GLP-1 Drug Peptide API market. It includes factors influencing customer ' purchasing decisions, preferences for GLP-1 Drug Peptide API product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the GLP-1 Drug Peptide API market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting GLP-1 Drug Peptide API market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the GLP-1 Drug Peptide API market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the GLP-1 Drug Peptide API industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the GLP-1 Drug Peptide API market.
Market Segmentation:
GLP-1 Drug Peptide API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Semaglutide
- Liraglutide
- Tilpotide
- Diabetes
- Obesity
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CPC Scientific
- Novo Nordisk
- Teva Pharmaceutical Industries Ltd
- JYMedtech
- Zhejiang Peptites Biotech
- Shengnuo Biotechnology
- Suzhou Tianma Pharmaceutical
- SINOPEP
- WuXi AppTec
- HYBIO Pharmaceutical
What is the 10-year outlook for the global GLP-1 Drug Peptide API market?
What factors are driving GLP-1 Drug Peptide API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do GLP-1 Drug Peptide API market opportunities vary by end market size?
How does GLP-1 Drug Peptide API break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GLP-1 Drug Peptide API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for GLP-1 Drug Peptide API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for GLP-1 Drug Peptide API by Country/Region, 2018, 2022 & 2029
2.2 GLP-1 Drug Peptide API Segment by Type
2.2.1 Semaglutide
2.2.2 Liraglutide
2.2.3 Tilpotide
2.3 GLP-1 Drug Peptide API Sales by Type
2.3.1 Global GLP-1 Drug Peptide API Sales Market Share by Type (2018-2023)
2.3.2 Global GLP-1 Drug Peptide API Revenue and Market Share by Type (2018-2023)
2.3.3 Global GLP-1 Drug Peptide API Sale Price by Type (2018-2023)
2.4 GLP-1 Drug Peptide API Segment by Application
2.4.1 Diabetes
2.4.2 Obesity
2.4.3 Other
2.5 GLP-1 Drug Peptide API Sales by Application
2.5.1 Global GLP-1 Drug Peptide API Sale Market Share by Application (2018-2023)
2.5.2 Global GLP-1 Drug Peptide API Revenue and Market Share by Application (2018-2023)
2.5.3 Global GLP-1 Drug Peptide API Sale Price by Application (2018-2023)
3 GLOBAL GLP-1 DRUG PEPTIDE API BY COMPANY
3.1 Global GLP-1 Drug Peptide API Breakdown Data by Company
3.1.1 Global GLP-1 Drug Peptide API Annual Sales by Company (2018-2023)
3.1.2 Global GLP-1 Drug Peptide API Sales Market Share by Company (2018-2023)
3.2 Global GLP-1 Drug Peptide API Annual Revenue by Company (2018-2023)
3.2.1 Global GLP-1 Drug Peptide API Revenue by Company (2018-2023)
3.2.2 Global GLP-1 Drug Peptide API Revenue Market Share by Company (2018-2023)
3.3 Global GLP-1 Drug Peptide API Sale Price by Company
3.4 Key Manufacturers GLP-1 Drug Peptide API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GLP-1 Drug Peptide API Product Location Distribution
3.4.2 Players GLP-1 Drug Peptide API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GLP-1 DRUG PEPTIDE API BY GEOGRAPHIC REGION
4.1 World Historic GLP-1 Drug Peptide API Market Size by Geographic Region (2018-2023)
4.1.1 Global GLP-1 Drug Peptide API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global GLP-1 Drug Peptide API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic GLP-1 Drug Peptide API Market Size by Country/Region (2018-2023)
4.2.1 Global GLP-1 Drug Peptide API Annual Sales by Country/Region (2018-2023)
4.2.2 Global GLP-1 Drug Peptide API Annual Revenue by Country/Region (2018-2023)
4.3 Americas GLP-1 Drug Peptide API Sales Growth
4.4 APAC GLP-1 Drug Peptide API Sales Growth
4.5 Europe GLP-1 Drug Peptide API Sales Growth
4.6 Middle East & Africa GLP-1 Drug Peptide API Sales Growth
5 AMERICAS
5.1 Americas GLP-1 Drug Peptide API Sales by Country
5.1.1 Americas GLP-1 Drug Peptide API Sales by Country (2018-2023)
5.1.2 Americas GLP-1 Drug Peptide API Revenue by Country (2018-2023)
5.2 Americas GLP-1 Drug Peptide API Sales by Type
5.3 Americas GLP-1 Drug Peptide API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GLP-1 Drug Peptide API Sales by Region
6.1.1 APAC GLP-1 Drug Peptide API Sales by Region (2018-2023)
6.1.2 APAC GLP-1 Drug Peptide API Revenue by Region (2018-2023)
6.2 APAC GLP-1 Drug Peptide API Sales by Type
6.3 APAC GLP-1 Drug Peptide API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GLP-1 Drug Peptide API by Country
7.1.1 Europe GLP-1 Drug Peptide API Sales by Country (2018-2023)
7.1.2 Europe GLP-1 Drug Peptide API Revenue by Country (2018-2023)
7.2 Europe GLP-1 Drug Peptide API Sales by Type
7.3 Europe GLP-1 Drug Peptide API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GLP-1 Drug Peptide API by Country
8.1.1 Middle East & Africa GLP-1 Drug Peptide API Sales by Country (2018-2023)
8.1.2 Middle East & Africa GLP-1 Drug Peptide API Revenue by Country (2018-2023)
8.2 Middle East & Africa GLP-1 Drug Peptide API Sales by Type
8.3 Middle East & Africa GLP-1 Drug Peptide API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1 Drug Peptide API
10.3 Manufacturing Process Analysis of GLP-1 Drug Peptide API
10.4 Industry Chain Structure of GLP-1 Drug Peptide API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GLP-1 Drug Peptide API Distributors
11.3 GLP-1 Drug Peptide API Customer
12 WORLD FORECAST REVIEW FOR GLP-1 DRUG PEPTIDE API BY GEOGRAPHIC REGION
12.1 Global GLP-1 Drug Peptide API Market Size Forecast by Region
12.1.1 Global GLP-1 Drug Peptide API Forecast by Region (2024-2029)
12.1.2 Global GLP-1 Drug Peptide API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global GLP-1 Drug Peptide API Forecast by Type
12.7 Global GLP-1 Drug Peptide API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 CPC Scientific
13.1.1 CPC Scientific Company Information
13.1.2 CPC Scientific GLP-1 Drug Peptide API Product Portfolios and Specifications
13.1.3 CPC Scientific GLP-1 Drug Peptide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 CPC Scientific Main Business Overview
13.1.5 CPC Scientific Latest Developments
13.2 Novo Nordisk
13.2.1 Novo Nordisk Company Information
13.2.2 Novo Nordisk GLP-1 Drug Peptide API Product Portfolios and Specifications
13.2.3 Novo Nordisk GLP-1 Drug Peptide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Novo Nordisk Main Business Overview
13.2.5 Novo Nordisk Latest Developments
13.3 Teva Pharmaceutical Industries Ltd
13.3.1 Teva Pharmaceutical Industries Ltd Company Information
13.3.2 Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Product Portfolios and Specifications
13.3.3 Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.3.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.4 JYMedtech
13.4.1 JYMedtech Company Information
13.4.2 JYMedtech GLP-1 Drug Peptide API Product Portfolios and Specifications
13.4.3 JYMedtech GLP-1 Drug Peptide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 JYMedtech Main Business Overview
13.4.5 JYMedtech Latest Developments
13.5 Zhejiang Peptites Biotech
13.5.1 Zhejiang Peptites Biotech Company Information
13.5.2 Zhejiang Peptites Biotech GLP-1 Drug Peptide API Product Portfolios and Specifications
13.5.3 Zhejiang Peptites Biotech GLP-1 Drug Peptide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Zhejiang Peptites Biotech Main Business Overview
13.5.5 Zhejiang Peptites Biotech Latest Developments
13.6 Shengnuo Biotechnology
13.6.1 Shengnuo Biotechnology Company Information
13.6.2 Shengnuo Biotechnology GLP-1 Drug Peptide API Product Portfolios and Specifications
13.6.3 Shengnuo Biotechnology GLP-1 Drug Peptide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Shengnuo Biotechnology Main Business Overview
13.6.5 Shengnuo Biotechnology Latest Developments
13.7 Suzhou Tianma Pharmaceutical
13.7.1 Suzhou Tianma Pharmaceutical Company Information
13.7.2 Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Product Portfolios and Specifications
13.7.3 Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Suzhou Tianma Pharmaceutical Main Business Overview
13.7.5 Suzhou Tianma Pharmaceutical Latest Developments
13.8 SINOPEP
13.8.1 SINOPEP Company Information
13.8.2 SINOPEP GLP-1 Drug Peptide API Product Portfolios and Specifications
13.8.3 SINOPEP GLP-1 Drug Peptide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 SINOPEP Main Business Overview
13.8.5 SINOPEP Latest Developments
13.9 WuXi AppTec
13.9.1 WuXi AppTec Company Information
13.9.2 WuXi AppTec GLP-1 Drug Peptide API Product Portfolios and Specifications
13.9.3 WuXi AppTec GLP-1 Drug Peptide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 WuXi AppTec Main Business Overview
13.9.5 WuXi AppTec Latest Developments
13.10 HYBIO Pharmaceutical
13.10.1 HYBIO Pharmaceutical Company Information
13.10.2 HYBIO Pharmaceutical GLP-1 Drug Peptide API Product Portfolios and Specifications
13.10.3 HYBIO Pharmaceutical GLP-1 Drug Peptide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 HYBIO Pharmaceutical Main Business Overview
13.10.5 HYBIO Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GLP-1 Drug Peptide API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for GLP-1 Drug Peptide API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for GLP-1 Drug Peptide API by Country/Region, 2018, 2022 & 2029
2.2 GLP-1 Drug Peptide API Segment by Type
2.2.1 Semaglutide
2.2.2 Liraglutide
2.2.3 Tilpotide
2.3 GLP-1 Drug Peptide API Sales by Type
2.3.1 Global GLP-1 Drug Peptide API Sales Market Share by Type (2018-2023)
2.3.2 Global GLP-1 Drug Peptide API Revenue and Market Share by Type (2018-2023)
2.3.3 Global GLP-1 Drug Peptide API Sale Price by Type (2018-2023)
2.4 GLP-1 Drug Peptide API Segment by Application
2.4.1 Diabetes
2.4.2 Obesity
2.4.3 Other
2.5 GLP-1 Drug Peptide API Sales by Application
2.5.1 Global GLP-1 Drug Peptide API Sale Market Share by Application (2018-2023)
2.5.2 Global GLP-1 Drug Peptide API Revenue and Market Share by Application (2018-2023)
2.5.3 Global GLP-1 Drug Peptide API Sale Price by Application (2018-2023)
3 GLOBAL GLP-1 DRUG PEPTIDE API BY COMPANY
3.1 Global GLP-1 Drug Peptide API Breakdown Data by Company
3.1.1 Global GLP-1 Drug Peptide API Annual Sales by Company (2018-2023)
3.1.2 Global GLP-1 Drug Peptide API Sales Market Share by Company (2018-2023)
3.2 Global GLP-1 Drug Peptide API Annual Revenue by Company (2018-2023)
3.2.1 Global GLP-1 Drug Peptide API Revenue by Company (2018-2023)
3.2.2 Global GLP-1 Drug Peptide API Revenue Market Share by Company (2018-2023)
3.3 Global GLP-1 Drug Peptide API Sale Price by Company
3.4 Key Manufacturers GLP-1 Drug Peptide API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GLP-1 Drug Peptide API Product Location Distribution
3.4.2 Players GLP-1 Drug Peptide API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GLP-1 DRUG PEPTIDE API BY GEOGRAPHIC REGION
4.1 World Historic GLP-1 Drug Peptide API Market Size by Geographic Region (2018-2023)
4.1.1 Global GLP-1 Drug Peptide API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global GLP-1 Drug Peptide API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic GLP-1 Drug Peptide API Market Size by Country/Region (2018-2023)
4.2.1 Global GLP-1 Drug Peptide API Annual Sales by Country/Region (2018-2023)
4.2.2 Global GLP-1 Drug Peptide API Annual Revenue by Country/Region (2018-2023)
4.3 Americas GLP-1 Drug Peptide API Sales Growth
4.4 APAC GLP-1 Drug Peptide API Sales Growth
4.5 Europe GLP-1 Drug Peptide API Sales Growth
4.6 Middle East & Africa GLP-1 Drug Peptide API Sales Growth
5 AMERICAS
5.1 Americas GLP-1 Drug Peptide API Sales by Country
5.1.1 Americas GLP-1 Drug Peptide API Sales by Country (2018-2023)
5.1.2 Americas GLP-1 Drug Peptide API Revenue by Country (2018-2023)
5.2 Americas GLP-1 Drug Peptide API Sales by Type
5.3 Americas GLP-1 Drug Peptide API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GLP-1 Drug Peptide API Sales by Region
6.1.1 APAC GLP-1 Drug Peptide API Sales by Region (2018-2023)
6.1.2 APAC GLP-1 Drug Peptide API Revenue by Region (2018-2023)
6.2 APAC GLP-1 Drug Peptide API Sales by Type
6.3 APAC GLP-1 Drug Peptide API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GLP-1 Drug Peptide API by Country
7.1.1 Europe GLP-1 Drug Peptide API Sales by Country (2018-2023)
7.1.2 Europe GLP-1 Drug Peptide API Revenue by Country (2018-2023)
7.2 Europe GLP-1 Drug Peptide API Sales by Type
7.3 Europe GLP-1 Drug Peptide API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GLP-1 Drug Peptide API by Country
8.1.1 Middle East & Africa GLP-1 Drug Peptide API Sales by Country (2018-2023)
8.1.2 Middle East & Africa GLP-1 Drug Peptide API Revenue by Country (2018-2023)
8.2 Middle East & Africa GLP-1 Drug Peptide API Sales by Type
8.3 Middle East & Africa GLP-1 Drug Peptide API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1 Drug Peptide API
10.3 Manufacturing Process Analysis of GLP-1 Drug Peptide API
10.4 Industry Chain Structure of GLP-1 Drug Peptide API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GLP-1 Drug Peptide API Distributors
11.3 GLP-1 Drug Peptide API Customer
12 WORLD FORECAST REVIEW FOR GLP-1 DRUG PEPTIDE API BY GEOGRAPHIC REGION
12.1 Global GLP-1 Drug Peptide API Market Size Forecast by Region
12.1.1 Global GLP-1 Drug Peptide API Forecast by Region (2024-2029)
12.1.2 Global GLP-1 Drug Peptide API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global GLP-1 Drug Peptide API Forecast by Type
12.7 Global GLP-1 Drug Peptide API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 CPC Scientific
13.1.1 CPC Scientific Company Information
13.1.2 CPC Scientific GLP-1 Drug Peptide API Product Portfolios and Specifications
13.1.3 CPC Scientific GLP-1 Drug Peptide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 CPC Scientific Main Business Overview
13.1.5 CPC Scientific Latest Developments
13.2 Novo Nordisk
13.2.1 Novo Nordisk Company Information
13.2.2 Novo Nordisk GLP-1 Drug Peptide API Product Portfolios and Specifications
13.2.3 Novo Nordisk GLP-1 Drug Peptide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Novo Nordisk Main Business Overview
13.2.5 Novo Nordisk Latest Developments
13.3 Teva Pharmaceutical Industries Ltd
13.3.1 Teva Pharmaceutical Industries Ltd Company Information
13.3.2 Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Product Portfolios and Specifications
13.3.3 Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.3.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.4 JYMedtech
13.4.1 JYMedtech Company Information
13.4.2 JYMedtech GLP-1 Drug Peptide API Product Portfolios and Specifications
13.4.3 JYMedtech GLP-1 Drug Peptide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 JYMedtech Main Business Overview
13.4.5 JYMedtech Latest Developments
13.5 Zhejiang Peptites Biotech
13.5.1 Zhejiang Peptites Biotech Company Information
13.5.2 Zhejiang Peptites Biotech GLP-1 Drug Peptide API Product Portfolios and Specifications
13.5.3 Zhejiang Peptites Biotech GLP-1 Drug Peptide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Zhejiang Peptites Biotech Main Business Overview
13.5.5 Zhejiang Peptites Biotech Latest Developments
13.6 Shengnuo Biotechnology
13.6.1 Shengnuo Biotechnology Company Information
13.6.2 Shengnuo Biotechnology GLP-1 Drug Peptide API Product Portfolios and Specifications
13.6.3 Shengnuo Biotechnology GLP-1 Drug Peptide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Shengnuo Biotechnology Main Business Overview
13.6.5 Shengnuo Biotechnology Latest Developments
13.7 Suzhou Tianma Pharmaceutical
13.7.1 Suzhou Tianma Pharmaceutical Company Information
13.7.2 Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Product Portfolios and Specifications
13.7.3 Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Suzhou Tianma Pharmaceutical Main Business Overview
13.7.5 Suzhou Tianma Pharmaceutical Latest Developments
13.8 SINOPEP
13.8.1 SINOPEP Company Information
13.8.2 SINOPEP GLP-1 Drug Peptide API Product Portfolios and Specifications
13.8.3 SINOPEP GLP-1 Drug Peptide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 SINOPEP Main Business Overview
13.8.5 SINOPEP Latest Developments
13.9 WuXi AppTec
13.9.1 WuXi AppTec Company Information
13.9.2 WuXi AppTec GLP-1 Drug Peptide API Product Portfolios and Specifications
13.9.3 WuXi AppTec GLP-1 Drug Peptide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 WuXi AppTec Main Business Overview
13.9.5 WuXi AppTec Latest Developments
13.10 HYBIO Pharmaceutical
13.10.1 HYBIO Pharmaceutical Company Information
13.10.2 HYBIO Pharmaceutical GLP-1 Drug Peptide API Product Portfolios and Specifications
13.10.3 HYBIO Pharmaceutical GLP-1 Drug Peptide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 HYBIO Pharmaceutical Main Business Overview
13.10.5 HYBIO Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. GLP-1 Drug Peptide API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. GLP-1 Drug Peptide API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Semaglutide
Table 4. Major Players of Liraglutide
Table 5. Major Players of Tilpotide
Table 6. Global GLP-1 Drug Peptide API Sales by Type (2018-2023) & (Tons)
Table 7. Global GLP-1 Drug Peptide API Sales Market Share by Type (2018-2023)
Table 8. Global GLP-1 Drug Peptide API Revenue by Type (2018-2023) & ($ million)
Table 9. Global GLP-1 Drug Peptide API Revenue Market Share by Type (2018-2023)
Table 10. Global GLP-1 Drug Peptide API Sale Price by Type (2018-2023) & (US$/Ton)
Table 11. Global GLP-1 Drug Peptide API Sales by Application (2018-2023) & (Tons)
Table 12. Global GLP-1 Drug Peptide API Sales Market Share by Application (2018-2023)
Table 13. Global GLP-1 Drug Peptide API Revenue by Application (2018-2023)
Table 14. Global GLP-1 Drug Peptide API Revenue Market Share by Application (2018-2023)
Table 15. Global GLP-1 Drug Peptide API Sale Price by Application (2018-2023) & (US$/Ton)
Table 16. Global GLP-1 Drug Peptide API Sales by Company (2018-2023) & (Tons)
Table 17. Global GLP-1 Drug Peptide API Sales Market Share by Company (2018-2023)
Table 18. Global GLP-1 Drug Peptide API Revenue by Company (2018-2023) ($ Millions)
Table 19. Global GLP-1 Drug Peptide API Revenue Market Share by Company (2018-2023)
Table 20. Global GLP-1 Drug Peptide API Sale Price by Company (2018-2023) & (US$/Ton)
Table 21. Key Manufacturers GLP-1 Drug Peptide API Producing Area Distribution and Sales Area
Table 22. Players GLP-1 Drug Peptide API Products Offered
Table 23. GLP-1 Drug Peptide API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global GLP-1 Drug Peptide API Sales by Geographic Region (2018-2023) & (Tons)
Table 27. Global GLP-1 Drug Peptide API Sales Market Share Geographic Region (2018-2023)
Table 28. Global GLP-1 Drug Peptide API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global GLP-1 Drug Peptide API Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global GLP-1 Drug Peptide API Sales by Country/Region (2018-2023) & (Tons)
Table 31. Global GLP-1 Drug Peptide API Sales Market Share by Country/Region (2018-2023)
Table 32. Global GLP-1 Drug Peptide API Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global GLP-1 Drug Peptide API Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas GLP-1 Drug Peptide API Sales by Country (2018-2023) & (Tons)
Table 35. Americas GLP-1 Drug Peptide API Sales Market Share by Country (2018-2023)
Table 36. Americas GLP-1 Drug Peptide API Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas GLP-1 Drug Peptide API Revenue Market Share by Country (2018-2023)
Table 38. Americas GLP-1 Drug Peptide API Sales by Type (2018-2023) & (Tons)
Table 39. Americas GLP-1 Drug Peptide API Sales by Application (2018-2023) & (Tons)
Table 40. APAC GLP-1 Drug Peptide API Sales by Region (2018-2023) & (Tons)
Table 41. APAC GLP-1 Drug Peptide API Sales Market Share by Region (2018-2023)
Table 42. APAC GLP-1 Drug Peptide API Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC GLP-1 Drug Peptide API Revenue Market Share by Region (2018-2023)
Table 44. APAC GLP-1 Drug Peptide API Sales by Type (2018-2023) & (Tons)
Table 45. APAC GLP-1 Drug Peptide API Sales by Application (2018-2023) & (Tons)
Table 46. Europe GLP-1 Drug Peptide API Sales by Country (2018-2023) & (Tons)
Table 47. Europe GLP-1 Drug Peptide API Sales Market Share by Country (2018-2023)
Table 48. Europe GLP-1 Drug Peptide API Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe GLP-1 Drug Peptide API Revenue Market Share by Country (2018-2023)
Table 50. Europe GLP-1 Drug Peptide API Sales by Type (2018-2023) & (Tons)
Table 51. Europe GLP-1 Drug Peptide API Sales by Application (2018-2023) & (Tons)
Table 52. Middle East & Africa GLP-1 Drug Peptide API Sales by Country (2018-2023) & (Tons)
Table 53. Middle East & Africa GLP-1 Drug Peptide API Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa GLP-1 Drug Peptide API Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa GLP-1 Drug Peptide API Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa GLP-1 Drug Peptide API Sales by Type (2018-2023) & (Tons)
Table 57. Middle East & Africa GLP-1 Drug Peptide API Sales by Application (2018-2023) & (Tons)
Table 58. Key Market Drivers & Growth Opportunities of GLP-1 Drug Peptide API
Table 59. Key Market Challenges & Risks of GLP-1 Drug Peptide API
Table 60. Key Industry Trends of GLP-1 Drug Peptide API
Table 61. GLP-1 Drug Peptide API Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. GLP-1 Drug Peptide API Distributors List
Table 64. GLP-1 Drug Peptide API Customer List
Table 65. Global GLP-1 Drug Peptide API Sales Forecast by Region (2024-2029) & (Tons)
Table 66. Global GLP-1 Drug Peptide API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas GLP-1 Drug Peptide API Sales Forecast by Country (2024-2029) & (Tons)
Table 68. Americas GLP-1 Drug Peptide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC GLP-1 Drug Peptide API Sales Forecast by Region (2024-2029) & (Tons)
Table 70. APAC GLP-1 Drug Peptide API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe GLP-1 Drug Peptide API Sales Forecast by Country (2024-2029) & (Tons)
Table 72. Europe GLP-1 Drug Peptide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa GLP-1 Drug Peptide API Sales Forecast by Country (2024-2029) & (Tons)
Table 74. Middle East & Africa GLP-1 Drug Peptide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global GLP-1 Drug Peptide API Sales Forecast by Type (2024-2029) & (Tons)
Table 76. Global GLP-1 Drug Peptide API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global GLP-1 Drug Peptide API Sales Forecast by Application (2024-2029) & (Tons)
Table 78. Global GLP-1 Drug Peptide API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. CPC Scientific Basic Information, GLP-1 Drug Peptide API Manufacturing Base, Sales Area and Its Competitors
Table 80. CPC Scientific GLP-1 Drug Peptide API Product Portfolios and Specifications
Table 81. CPC Scientific GLP-1 Drug Peptide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 82. CPC Scientific Main Business
Table 83. CPC Scientific Latest Developments
Table 84. Novo Nordisk Basic Information, GLP-1 Drug Peptide API Manufacturing Base, Sales Area and Its Competitors
Table 85. Novo Nordisk GLP-1 Drug Peptide API Product Portfolios and Specifications
Table 86. Novo Nordisk GLP-1 Drug Peptide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 87. Novo Nordisk Main Business
Table 88. Novo Nordisk Latest Developments
Table 89. Teva Pharmaceutical Industries Ltd Basic Information, GLP-1 Drug Peptide API Manufacturing Base, Sales Area and Its Competitors
Table 90. Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Product Portfolios and Specifications
Table 91. Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 92. Teva Pharmaceutical Industries Ltd Main Business
Table 93. Teva Pharmaceutical Industries Ltd Latest Developments
Table 94. JYMedtech Basic Information, GLP-1 Drug Peptide API Manufacturing Base, Sales Area and Its Competitors
Table 95. JYMedtech GLP-1 Drug Peptide API Product Portfolios and Specifications
Table 96. JYMedtech GLP-1 Drug Peptide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 97. JYMedtech Main Business
Table 98. JYMedtech Latest Developments
Table 99. Zhejiang Peptites Biotech Basic Information, GLP-1 Drug Peptide API Manufacturing Base, Sales Area and Its Competitors
Table 100. Zhejiang Peptites Biotech GLP-1 Drug Peptide API Product Portfolios and Specifications
Table 101. Zhejiang Peptites Biotech GLP-1 Drug Peptide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 102. Zhejiang Peptites Biotech Main Business
Table 103. Zhejiang Peptites Biotech Latest Developments
Table 104. Shengnuo Biotechnology Basic Information, GLP-1 Drug Peptide API Manufacturing Base, Sales Area and Its Competitors
Table 105. Shengnuo Biotechnology GLP-1 Drug Peptide API Product Portfolios and Specifications
Table 106. Shengnuo Biotechnology GLP-1 Drug Peptide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 107. Shengnuo Biotechnology Main Business
Table 108. Shengnuo Biotechnology Latest Developments
Table 109. Suzhou Tianma Pharmaceutical Basic Information, GLP-1 Drug Peptide API Manufacturing Base, Sales Area and Its Competitors
Table 110. Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Product Portfolios and Specifications
Table 111. Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 112. Suzhou Tianma Pharmaceutical Main Business
Table 113. Suzhou Tianma Pharmaceutical Latest Developments
Table 114. SINOPEP Basic Information, GLP-1 Drug Peptide API Manufacturing Base, Sales Area and Its Competitors
Table 115. SINOPEP GLP-1 Drug Peptide API Product Portfolios and Specifications
Table 116. SINOPEP GLP-1 Drug Peptide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 117. SINOPEP Main Business
Table 118. SINOPEP Latest Developments
Table 119. WuXi AppTec Basic Information, GLP-1 Drug Peptide API Manufacturing Base, Sales Area and Its Competitors
Table 120. WuXi AppTec GLP-1 Drug Peptide API Product Portfolios and Specifications
Table 121. WuXi AppTec GLP-1 Drug Peptide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 122. WuXi AppTec Main Business
Table 123. WuXi AppTec Latest Developments
Table 124. HYBIO Pharmaceutical Basic Information, GLP-1 Drug Peptide API Manufacturing Base, Sales Area and Its Competitors
Table 125. HYBIO Pharmaceutical GLP-1 Drug Peptide API Product Portfolios and Specifications
Table 126. HYBIO Pharmaceutical GLP-1 Drug Peptide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 127. HYBIO Pharmaceutical Main Business
Table 128. HYBIO Pharmaceutical Latest Developments
Table 1. GLP-1 Drug Peptide API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. GLP-1 Drug Peptide API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Semaglutide
Table 4. Major Players of Liraglutide
Table 5. Major Players of Tilpotide
Table 6. Global GLP-1 Drug Peptide API Sales by Type (2018-2023) & (Tons)
Table 7. Global GLP-1 Drug Peptide API Sales Market Share by Type (2018-2023)
Table 8. Global GLP-1 Drug Peptide API Revenue by Type (2018-2023) & ($ million)
Table 9. Global GLP-1 Drug Peptide API Revenue Market Share by Type (2018-2023)
Table 10. Global GLP-1 Drug Peptide API Sale Price by Type (2018-2023) & (US$/Ton)
Table 11. Global GLP-1 Drug Peptide API Sales by Application (2018-2023) & (Tons)
Table 12. Global GLP-1 Drug Peptide API Sales Market Share by Application (2018-2023)
Table 13. Global GLP-1 Drug Peptide API Revenue by Application (2018-2023)
Table 14. Global GLP-1 Drug Peptide API Revenue Market Share by Application (2018-2023)
Table 15. Global GLP-1 Drug Peptide API Sale Price by Application (2018-2023) & (US$/Ton)
Table 16. Global GLP-1 Drug Peptide API Sales by Company (2018-2023) & (Tons)
Table 17. Global GLP-1 Drug Peptide API Sales Market Share by Company (2018-2023)
Table 18. Global GLP-1 Drug Peptide API Revenue by Company (2018-2023) ($ Millions)
Table 19. Global GLP-1 Drug Peptide API Revenue Market Share by Company (2018-2023)
Table 20. Global GLP-1 Drug Peptide API Sale Price by Company (2018-2023) & (US$/Ton)
Table 21. Key Manufacturers GLP-1 Drug Peptide API Producing Area Distribution and Sales Area
Table 22. Players GLP-1 Drug Peptide API Products Offered
Table 23. GLP-1 Drug Peptide API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global GLP-1 Drug Peptide API Sales by Geographic Region (2018-2023) & (Tons)
Table 27. Global GLP-1 Drug Peptide API Sales Market Share Geographic Region (2018-2023)
Table 28. Global GLP-1 Drug Peptide API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global GLP-1 Drug Peptide API Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global GLP-1 Drug Peptide API Sales by Country/Region (2018-2023) & (Tons)
Table 31. Global GLP-1 Drug Peptide API Sales Market Share by Country/Region (2018-2023)
Table 32. Global GLP-1 Drug Peptide API Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global GLP-1 Drug Peptide API Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas GLP-1 Drug Peptide API Sales by Country (2018-2023) & (Tons)
Table 35. Americas GLP-1 Drug Peptide API Sales Market Share by Country (2018-2023)
Table 36. Americas GLP-1 Drug Peptide API Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas GLP-1 Drug Peptide API Revenue Market Share by Country (2018-2023)
Table 38. Americas GLP-1 Drug Peptide API Sales by Type (2018-2023) & (Tons)
Table 39. Americas GLP-1 Drug Peptide API Sales by Application (2018-2023) & (Tons)
Table 40. APAC GLP-1 Drug Peptide API Sales by Region (2018-2023) & (Tons)
Table 41. APAC GLP-1 Drug Peptide API Sales Market Share by Region (2018-2023)
Table 42. APAC GLP-1 Drug Peptide API Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC GLP-1 Drug Peptide API Revenue Market Share by Region (2018-2023)
Table 44. APAC GLP-1 Drug Peptide API Sales by Type (2018-2023) & (Tons)
Table 45. APAC GLP-1 Drug Peptide API Sales by Application (2018-2023) & (Tons)
Table 46. Europe GLP-1 Drug Peptide API Sales by Country (2018-2023) & (Tons)
Table 47. Europe GLP-1 Drug Peptide API Sales Market Share by Country (2018-2023)
Table 48. Europe GLP-1 Drug Peptide API Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe GLP-1 Drug Peptide API Revenue Market Share by Country (2018-2023)
Table 50. Europe GLP-1 Drug Peptide API Sales by Type (2018-2023) & (Tons)
Table 51. Europe GLP-1 Drug Peptide API Sales by Application (2018-2023) & (Tons)
Table 52. Middle East & Africa GLP-1 Drug Peptide API Sales by Country (2018-2023) & (Tons)
Table 53. Middle East & Africa GLP-1 Drug Peptide API Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa GLP-1 Drug Peptide API Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa GLP-1 Drug Peptide API Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa GLP-1 Drug Peptide API Sales by Type (2018-2023) & (Tons)
Table 57. Middle East & Africa GLP-1 Drug Peptide API Sales by Application (2018-2023) & (Tons)
Table 58. Key Market Drivers & Growth Opportunities of GLP-1 Drug Peptide API
Table 59. Key Market Challenges & Risks of GLP-1 Drug Peptide API
Table 60. Key Industry Trends of GLP-1 Drug Peptide API
Table 61. GLP-1 Drug Peptide API Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. GLP-1 Drug Peptide API Distributors List
Table 64. GLP-1 Drug Peptide API Customer List
Table 65. Global GLP-1 Drug Peptide API Sales Forecast by Region (2024-2029) & (Tons)
Table 66. Global GLP-1 Drug Peptide API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas GLP-1 Drug Peptide API Sales Forecast by Country (2024-2029) & (Tons)
Table 68. Americas GLP-1 Drug Peptide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC GLP-1 Drug Peptide API Sales Forecast by Region (2024-2029) & (Tons)
Table 70. APAC GLP-1 Drug Peptide API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe GLP-1 Drug Peptide API Sales Forecast by Country (2024-2029) & (Tons)
Table 72. Europe GLP-1 Drug Peptide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa GLP-1 Drug Peptide API Sales Forecast by Country (2024-2029) & (Tons)
Table 74. Middle East & Africa GLP-1 Drug Peptide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global GLP-1 Drug Peptide API Sales Forecast by Type (2024-2029) & (Tons)
Table 76. Global GLP-1 Drug Peptide API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global GLP-1 Drug Peptide API Sales Forecast by Application (2024-2029) & (Tons)
Table 78. Global GLP-1 Drug Peptide API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. CPC Scientific Basic Information, GLP-1 Drug Peptide API Manufacturing Base, Sales Area and Its Competitors
Table 80. CPC Scientific GLP-1 Drug Peptide API Product Portfolios and Specifications
Table 81. CPC Scientific GLP-1 Drug Peptide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 82. CPC Scientific Main Business
Table 83. CPC Scientific Latest Developments
Table 84. Novo Nordisk Basic Information, GLP-1 Drug Peptide API Manufacturing Base, Sales Area and Its Competitors
Table 85. Novo Nordisk GLP-1 Drug Peptide API Product Portfolios and Specifications
Table 86. Novo Nordisk GLP-1 Drug Peptide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 87. Novo Nordisk Main Business
Table 88. Novo Nordisk Latest Developments
Table 89. Teva Pharmaceutical Industries Ltd Basic Information, GLP-1 Drug Peptide API Manufacturing Base, Sales Area and Its Competitors
Table 90. Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Product Portfolios and Specifications
Table 91. Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 92. Teva Pharmaceutical Industries Ltd Main Business
Table 93. Teva Pharmaceutical Industries Ltd Latest Developments
Table 94. JYMedtech Basic Information, GLP-1 Drug Peptide API Manufacturing Base, Sales Area and Its Competitors
Table 95. JYMedtech GLP-1 Drug Peptide API Product Portfolios and Specifications
Table 96. JYMedtech GLP-1 Drug Peptide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 97. JYMedtech Main Business
Table 98. JYMedtech Latest Developments
Table 99. Zhejiang Peptites Biotech Basic Information, GLP-1 Drug Peptide API Manufacturing Base, Sales Area and Its Competitors
Table 100. Zhejiang Peptites Biotech GLP-1 Drug Peptide API Product Portfolios and Specifications
Table 101. Zhejiang Peptites Biotech GLP-1 Drug Peptide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 102. Zhejiang Peptites Biotech Main Business
Table 103. Zhejiang Peptites Biotech Latest Developments
Table 104. Shengnuo Biotechnology Basic Information, GLP-1 Drug Peptide API Manufacturing Base, Sales Area and Its Competitors
Table 105. Shengnuo Biotechnology GLP-1 Drug Peptide API Product Portfolios and Specifications
Table 106. Shengnuo Biotechnology GLP-1 Drug Peptide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 107. Shengnuo Biotechnology Main Business
Table 108. Shengnuo Biotechnology Latest Developments
Table 109. Suzhou Tianma Pharmaceutical Basic Information, GLP-1 Drug Peptide API Manufacturing Base, Sales Area and Its Competitors
Table 110. Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Product Portfolios and Specifications
Table 111. Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 112. Suzhou Tianma Pharmaceutical Main Business
Table 113. Suzhou Tianma Pharmaceutical Latest Developments
Table 114. SINOPEP Basic Information, GLP-1 Drug Peptide API Manufacturing Base, Sales Area and Its Competitors
Table 115. SINOPEP GLP-1 Drug Peptide API Product Portfolios and Specifications
Table 116. SINOPEP GLP-1 Drug Peptide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 117. SINOPEP Main Business
Table 118. SINOPEP Latest Developments
Table 119. WuXi AppTec Basic Information, GLP-1 Drug Peptide API Manufacturing Base, Sales Area and Its Competitors
Table 120. WuXi AppTec GLP-1 Drug Peptide API Product Portfolios and Specifications
Table 121. WuXi AppTec GLP-1 Drug Peptide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 122. WuXi AppTec Main Business
Table 123. WuXi AppTec Latest Developments
Table 124. HYBIO Pharmaceutical Basic Information, GLP-1 Drug Peptide API Manufacturing Base, Sales Area and Its Competitors
Table 125. HYBIO Pharmaceutical GLP-1 Drug Peptide API Product Portfolios and Specifications
Table 126. HYBIO Pharmaceutical GLP-1 Drug Peptide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 127. HYBIO Pharmaceutical Main Business
Table 128. HYBIO Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of GLP-1 Drug Peptide API
Figure 2. GLP-1 Drug Peptide API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1 Drug Peptide API Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global GLP-1 Drug Peptide API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. GLP-1 Drug Peptide API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Semaglutide
Figure 10. Product Picture of Liraglutide
Figure 11. Product Picture of Tilpotide
Figure 12. Global GLP-1 Drug Peptide API Sales Market Share by Type in 2022
Figure 13. Global GLP-1 Drug Peptide API Revenue Market Share by Type (2018-2023)
Figure 14. GLP-1 Drug Peptide API Consumed in Diabetes
Figure 15. Global GLP-1 Drug Peptide API Market: Diabetes (2018-2023) & (Tons)
Figure 16. GLP-1 Drug Peptide API Consumed in Obesity
Figure 17. Global GLP-1 Drug Peptide API Market: Obesity (2018-2023) & (Tons)
Figure 18. GLP-1 Drug Peptide API Consumed in Other
Figure 19. Global GLP-1 Drug Peptide API Market: Other (2018-2023) & (Tons)
Figure 20. Global GLP-1 Drug Peptide API Sales Market Share by Application (2022)
Figure 21. Global GLP-1 Drug Peptide API Revenue Market Share by Application in 2022
Figure 22. GLP-1 Drug Peptide API Sales Market by Company in 2022 (Tons)
Figure 23. Global GLP-1 Drug Peptide API Sales Market Share by Company in 2022
Figure 24. GLP-1 Drug Peptide API Revenue Market by Company in 2022 ($ Million)
Figure 25. Global GLP-1 Drug Peptide API Revenue Market Share by Company in 2022
Figure 26. Global GLP-1 Drug Peptide API Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global GLP-1 Drug Peptide API Revenue Market Share by Geographic Region in 2022
Figure 28. Americas GLP-1 Drug Peptide API Sales 2018-2023 (Tons)
Figure 29. Americas GLP-1 Drug Peptide API Revenue 2018-2023 ($ Millions)
Figure 30. APAC GLP-1 Drug Peptide API Sales 2018-2023 (Tons)
Figure 31. APAC GLP-1 Drug Peptide API Revenue 2018-2023 ($ Millions)
Figure 32. Europe GLP-1 Drug Peptide API Sales 2018-2023 (Tons)
Figure 33. Europe GLP-1 Drug Peptide API Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa GLP-1 Drug Peptide API Sales 2018-2023 (Tons)
Figure 35. Middle East & Africa GLP-1 Drug Peptide API Revenue 2018-2023 ($ Millions)
Figure 36. Americas GLP-1 Drug Peptide API Sales Market Share by Country in 2022
Figure 37. Americas GLP-1 Drug Peptide API Revenue Market Share by Country in 2022
Figure 38. Americas GLP-1 Drug Peptide API Sales Market Share by Type (2018-2023)
Figure 39. Americas GLP-1 Drug Peptide API Sales Market Share by Application (2018-2023)
Figure 40. United States GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC GLP-1 Drug Peptide API Sales Market Share by Region in 2022
Figure 45. APAC GLP-1 Drug Peptide API Revenue Market Share by Regions in 2022
Figure 46. APAC GLP-1 Drug Peptide API Sales Market Share by Type (2018-2023)
Figure 47. APAC GLP-1 Drug Peptide API Sales Market Share by Application (2018-2023)
Figure 48. China GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 52. India GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe GLP-1 Drug Peptide API Sales Market Share by Country in 2022
Figure 56. Europe GLP-1 Drug Peptide API Revenue Market Share by Country in 2022
Figure 57. Europe GLP-1 Drug Peptide API Sales Market Share by Type (2018-2023)
Figure 58. Europe GLP-1 Drug Peptide API Sales Market Share by Application (2018-2023)
Figure 59. Germany GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 60. France GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa GLP-1 Drug Peptide API Sales Market Share by Country in 2022
Figure 65. Middle East & Africa GLP-1 Drug Peptide API Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa GLP-1 Drug Peptide API Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa GLP-1 Drug Peptide API Sales Market Share by Application (2018-2023)
Figure 68. Egypt GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of GLP-1 Drug Peptide API in 2022
Figure 74. Manufacturing Process Analysis of GLP-1 Drug Peptide API
Figure 75. Industry Chain Structure of GLP-1 Drug Peptide API
Figure 76. Channels of Distribution
Figure 77. Global GLP-1 Drug Peptide API Sales Market Forecast by Region (2024-2029)
Figure 78. Global GLP-1 Drug Peptide API Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global GLP-1 Drug Peptide API Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global GLP-1 Drug Peptide API Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global GLP-1 Drug Peptide API Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global GLP-1 Drug Peptide API Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of GLP-1 Drug Peptide API
Figure 2. GLP-1 Drug Peptide API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1 Drug Peptide API Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global GLP-1 Drug Peptide API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. GLP-1 Drug Peptide API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Semaglutide
Figure 10. Product Picture of Liraglutide
Figure 11. Product Picture of Tilpotide
Figure 12. Global GLP-1 Drug Peptide API Sales Market Share by Type in 2022
Figure 13. Global GLP-1 Drug Peptide API Revenue Market Share by Type (2018-2023)
Figure 14. GLP-1 Drug Peptide API Consumed in Diabetes
Figure 15. Global GLP-1 Drug Peptide API Market: Diabetes (2018-2023) & (Tons)
Figure 16. GLP-1 Drug Peptide API Consumed in Obesity
Figure 17. Global GLP-1 Drug Peptide API Market: Obesity (2018-2023) & (Tons)
Figure 18. GLP-1 Drug Peptide API Consumed in Other
Figure 19. Global GLP-1 Drug Peptide API Market: Other (2018-2023) & (Tons)
Figure 20. Global GLP-1 Drug Peptide API Sales Market Share by Application (2022)
Figure 21. Global GLP-1 Drug Peptide API Revenue Market Share by Application in 2022
Figure 22. GLP-1 Drug Peptide API Sales Market by Company in 2022 (Tons)
Figure 23. Global GLP-1 Drug Peptide API Sales Market Share by Company in 2022
Figure 24. GLP-1 Drug Peptide API Revenue Market by Company in 2022 ($ Million)
Figure 25. Global GLP-1 Drug Peptide API Revenue Market Share by Company in 2022
Figure 26. Global GLP-1 Drug Peptide API Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global GLP-1 Drug Peptide API Revenue Market Share by Geographic Region in 2022
Figure 28. Americas GLP-1 Drug Peptide API Sales 2018-2023 (Tons)
Figure 29. Americas GLP-1 Drug Peptide API Revenue 2018-2023 ($ Millions)
Figure 30. APAC GLP-1 Drug Peptide API Sales 2018-2023 (Tons)
Figure 31. APAC GLP-1 Drug Peptide API Revenue 2018-2023 ($ Millions)
Figure 32. Europe GLP-1 Drug Peptide API Sales 2018-2023 (Tons)
Figure 33. Europe GLP-1 Drug Peptide API Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa GLP-1 Drug Peptide API Sales 2018-2023 (Tons)
Figure 35. Middle East & Africa GLP-1 Drug Peptide API Revenue 2018-2023 ($ Millions)
Figure 36. Americas GLP-1 Drug Peptide API Sales Market Share by Country in 2022
Figure 37. Americas GLP-1 Drug Peptide API Revenue Market Share by Country in 2022
Figure 38. Americas GLP-1 Drug Peptide API Sales Market Share by Type (2018-2023)
Figure 39. Americas GLP-1 Drug Peptide API Sales Market Share by Application (2018-2023)
Figure 40. United States GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC GLP-1 Drug Peptide API Sales Market Share by Region in 2022
Figure 45. APAC GLP-1 Drug Peptide API Revenue Market Share by Regions in 2022
Figure 46. APAC GLP-1 Drug Peptide API Sales Market Share by Type (2018-2023)
Figure 47. APAC GLP-1 Drug Peptide API Sales Market Share by Application (2018-2023)
Figure 48. China GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 52. India GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe GLP-1 Drug Peptide API Sales Market Share by Country in 2022
Figure 56. Europe GLP-1 Drug Peptide API Revenue Market Share by Country in 2022
Figure 57. Europe GLP-1 Drug Peptide API Sales Market Share by Type (2018-2023)
Figure 58. Europe GLP-1 Drug Peptide API Sales Market Share by Application (2018-2023)
Figure 59. Germany GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 60. France GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa GLP-1 Drug Peptide API Sales Market Share by Country in 2022
Figure 65. Middle East & Africa GLP-1 Drug Peptide API Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa GLP-1 Drug Peptide API Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa GLP-1 Drug Peptide API Sales Market Share by Application (2018-2023)
Figure 68. Egypt GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country GLP-1 Drug Peptide API Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of GLP-1 Drug Peptide API in 2022
Figure 74. Manufacturing Process Analysis of GLP-1 Drug Peptide API
Figure 75. Industry Chain Structure of GLP-1 Drug Peptide API
Figure 76. Channels of Distribution
Figure 77. Global GLP-1 Drug Peptide API Sales Market Forecast by Region (2024-2029)
Figure 78. Global GLP-1 Drug Peptide API Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global GLP-1 Drug Peptide API Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global GLP-1 Drug Peptide API Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global GLP-1 Drug Peptide API Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global GLP-1 Drug Peptide API Revenue Market Share Forecast by Application (2024-2029)
